diclofenac has been researched along with iloprost in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bekemeier, H; Hirschelmann, R | 1 |
| Schröder, H; Schrör, K | 1 |
| Bachvarov, DR; Bachvarova, M; Bouthillier, J; Houle, S; Larrivée, JF; Marceau, F | 1 |
| Ding, Z; Gödecke, A; Schrader, J; Ziegler, M | 1 |
| Bretschneider, E; Censarek, P; Fischer, JW; Meyer-Kirchrath, J; Pape, R; Rabausch, K; Sarbia, M; Schrör, K; Weber, AA | 1 |
| Lindahl, SG; Nyren, S; Rimeika, D; Sanchez-Crespo, A; Wiklund, CU | 1 |
| Doğan, A; Kalender, AM; Kılınçoğlu, V; Sebik, A; Toker, S; Uslu, M | 1 |
10 other study(ies) available for diclofenac and iloprost
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Role of eicosanoids in the kappa-carrageenin rat tail thrombosis.
Topics: Aminopyrine; Animals; Aspirin; Benzydamine; Cardiovascular Agents; Carrageenan; Diclofenac; Epoprostenol; Female; Iloprost; Imidazoles; Phenylbutazone; Rats; Rats, Inbred Strains; Thrombosis; Thromboxanes; Trapidil | 1988 |
Prostacyclin-dependent cyclic AMP formation in endothelial cells.
Topics: Animals; Cell Line; Cells, Cultured; Cyclic AMP; Diclofenac; Endothelium, Vascular; Epoprostenol; Iloprost; Indomethacin; Swine | 1993 |
Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Diclofenac; Down-Regulation; Duodenum; Enalapril; Female; Gene Expression Regulation; Heart; Histamine; Iloprost; In Vitro Techniques; Kinins; Lipopolysaccharides; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Prostaglandins; Rabbits; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 1999 |
Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Apolipoproteins E; Bradykinin; Cholesterol, LDL; Coronary Vessels; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Hypercholesterolemia; Iloprost; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Superoxide Dismutase; Vascular Resistance; Vasodilator Agents | 2002 |
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins.
Topics: Alprostadil; Blood Coagulation; Bucladesine; Carotid Artery Diseases; Carotid Artery, Internal; Cells, Cultured; Colforsin; Coronary Vessels; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Epoprostenol; Etoricoxib; Gene Expression Profiling; Gene Expression Regulation; Humans; Iloprost; Isoquinolines; Mammary Arteries; Membrane Proteins; Models, Biological; Myocytes, Smooth Muscle; Oligonucleotide Array Sequence Analysis; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyridines; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; RNA, Messenger; Saphenous Vein; Second Messenger Systems; Sulfonamides; Sulfones; Tetradecanoylphorbol Acetate; Thrombomodulin; Thrombophilia; Vasodilator Agents | 2005 |
Iloprost inhalation redistributes pulmonary perfusion and decreases arterial oxygenation in healthy volunteers.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Inhalation; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Female; Humans; Iloprost; Image Processing, Computer-Assisted; Lung; Male; Oxygen; Oxygen Consumption; Posture; Pulmonary Circulation; Pulmonary Gas Exchange; Respiratory Mechanics; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Comparison of anti-edema effects of iloprost and diclofenac sodium on traumatic rat paw edema.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Edema; Gels; Iloprost; Infusions, Parenteral; Male; Platelet Aggregation Inhibitors; Plethysmography; Rats; Rats, Sprague-Dawley; Soft Tissue Injuries; Wound Healing | 2010 |